Metabolic Protocols, Pancreatic Cancer
In this video, Bill FryGeronimo Rubio Sr. spends about 25 minutes speaking on "Metabolic Protocols, Pancreatic Cancer" at the 31st Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Geronimo Rubio Sr.
GERONIMO RUBIO, SR., M.D. has been the Medical Director of his own hospital for over three decades. He received his M.D. degree from the University of Autonoma de Baja California Medical School in Mexico. His research at Rubio Cancer Center specializes in immunology, customized cancer vaccines and adult stem cells for regenerative medicine for the treatment of cancer and chronic diseases. As a Medical Director and Research Director for over 30 years, Dr. Rubio’s specialties include: Oncology, Hematology, Physiology, Biochemistry, Bacteriology, Parasitology and Biomedical Engineering.
Dr. Rubio is certified by the FIMBR, The International Federation of Regenerative Medicine and in 2013 he received his diploma from the University of Puebla in Regenerative Medicine.
For the last 30 years, Dr. Rubio has researched and developed a process of RNA transference in lymphocytes, and polypeptide formulas for cancer cells and developed the formula for the blocking factors in tumor cells. He is presently the Medical Director of Rubio Cancer Center, located in La Mesa, Mexico, where his special Immune Vaccines are combined with Rife Technology and Herbal Medicines.
Rubio Cancer Center is one of the top ten hospitals in the country of Mexico, certified by the Mexican government to manufacture and apply adult stem cells and cancer vaccines. In 2015 Dr. Rubio received a certificate of recognition from the State of California, Senator Joel Anderson’s Office for his outstanding community service in Health Education. He is also the co-author of Breaking The Cancer Code, A Revolutionary Approach To Reversing Cancer, and is a popular lecturer at U.S. health and medical conferences. His reputation in reversing cancer is confirmed by Health authorities and written about by bestselling authors, who call him “The Tijuana Tumor Terminator.”
Dr. Rubio may be contacted by phone 866-246-0462, and websites www.RubioCancerCenter.com and www.BreakingTheCancerCode.com.
Transcription
Well, good afternoon. Such a pleasure being here, invited every year to speak. And today we're going to bring you to an update of Dr. Rubio's latest research of 19 years in autoimmune vaccines, the basis of our health care program.
And he'll be speaking specifically to Kant's cancer of the pancreas, pancreatic cancer today. And we also have Steve Altman with us today. One of our our patients will be greeting you after Dr. Rubio speaks and sharing his experience in turning around Pank. Pancreatic cancer, as you know, is one of the most very difficult cancers to turn around. And you can see we're making large inroads into turning this cancerous disease around that we haven't been able to do before. So at this time, I would like to introduce you to Dr. Geronimo Rovio, medical director of the American Metabolic Institute. He'll be speaking to you on pancreatic cancer. Thank you.
Good afternoon.
I'm Dr. Rubial, and today I will chair protocols about pancreatic cancer. We know pancreas is our organ.
They belong to our digestive tract, like cadastre, pancreas. They perform insulin and they perform enzymes. Can we find out, for example, the pancreas? You know, anatomically easy, divided in three places. There has a head body and a town. And a tumor can appear in any of these places. The most frequent place for the tumor to appear is in the head of the pancreas. But the most important here are the right now. Pancreatic cancer is a nine mors type of tumor in frequency.
Ten years ago was a number 16.
When a patient, you know, been diagnosed with pancreatic cancer already, this tumor is spread because pancreatic cancer is the most aggressive type of tumor, is the fasting, growing tumor that we have. When the patient go and they do to diagnose already a tumor is spread about thousands upon punk, just cancer. We have there is our family history patients.
We see the gene ratios like a fifth generation.
We find the is how they pass. The gene is most frequent in men.
They have a little link in their obesity, an exposure to a chemical environment right there. We are talking about Misener, that chromosome number three.
So is the only test that we can do to prevent pancreatic cancer. We can do the DNA test and we if we find a missing part of the chromosome number three, this patient will develop pancreatic cancer and they're in the bottom is the escape of the tumor from the immune system.
For diagnostic and diagnostic, for pancreatic cancer, we have the laboratory and laboratory Lucka. We do we do smocks overseas.
SeeI